What does Pharvaris NV do?

Jun 22 2025 06:58 PM IST
share
Share Via
Pharvaris NV is a micro-cap company in the Pharmaceuticals & Biotechnology industry, currently reporting a net profit loss of $49 million and a market cap of $902.41 million. Key metrics include a negative P/E ratio, no dividend yield, and a return on equity of -67.24%.
Overview:
Pharvaris NV operates in the Pharmaceuticals & Biotechnology industry and is classified as a micro-cap company.

Financial Snapshot:
Most recent Net Profit: -49 Million (Quarterly Results - Mar 2025)
Market cap: USD 902.41 Million (Micro Cap)

Key Metrics:
P/E: NA (Loss Making)
Industry P/E: NA
Dividend Yield: 0.00%
Debt Equity: -1.05
Return on Equity: -67.24%
Price to Book: 3.71

Contact Details:
Registrar Address: Not available.
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Is Pharvaris NV technically bullish or bearish?
Sep 20 2025 08:00 PM IST
share
Share Via
Is Pharvaris NV technically bullish or bearish?
Jun 25 2025 09:00 AM IST
share
Share Via
How big is Pharvaris NV?
Jun 22 2025 06:11 PM IST
share
Share Via